Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Debt Repayments (2016 - 2025)

Immucell's Long-Term Debt Repayments history spans 16 years, with the latest figure at $394602.0 for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments rose 5.44% year-over-year to $394602.0; the TTM value through Dec 2025 reached $2.3 million, up 55.31%, while the annual FY2025 figure was $2.3 million, 55.31% up from the prior year.
  • Long-Term Debt Repayments reached $394602.0 in Q4 2025 per ICCC's latest filing, down from $1.1 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.1 million in Q3 2025 to a low of $190377.0 in Q1 2021.
  • Average Long-Term Debt Repayments over 5 years is $329998.8, with a median of $288819.0 recorded in 2023.
  • Peak YoY movement for Long-Term Debt Repayments: tumbled 97.77% in 2021, then skyrocketed 205.32% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $194905.0 in 2021, then grew by 27.35% to $248207.0 in 2022, then skyrocketed by 43.73% to $356759.0 in 2023, then rose by 4.9% to $374232.0 in 2024, then rose by 5.44% to $394602.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Long-Term Debt Repayments are $394602.0 (Q4 2025), $1.1 million (Q3 2025), and $381438.0 (Q2 2025).